OrganiGram Historical Valuation

OGI Stock  USD 1.51  0.03  2.03%   
Some fundamental drivers such as market cap or OrganiGram Holdings enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze OrganiGram Holdings valuation indicators such as to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of OrganiGram Holdings's future value.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.

About OrganiGram Valuation Data Analysis

Valuation is the financial process of determining what OrganiGram Holdings is worth. OrganiGram Holdings valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. OrganiGram Holdings valuation ratios help investors to determine whether OrganiGram Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in OrganiGram with respect to the benefits of owning OrganiGram Holdings security.

OrganiGram Holdings Valuation Data Chart

The OrganiGram Holdings' current Market Cap is estimated to increase to about 455.6 M, while Enterprise Value is projected to decrease to under 185.5 M.

Enterprise Value

Enterprise Value (or EV) is usually referred to as OrganiGram Holdings theoretical takeover price. In the event of an acquisition, an acquirer would have to take on OrganiGram Holdings debt, but would also pocket its cash. Enterprise Value is more accurate representation of OrganiGram Holdings value than its market capitalization because it takes into account all of OrganiGram Holdings existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Currently Active Assets on Macroaxis

When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.83)
Revenue Per Share
1.835
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.06)
Return On Equity
(0.55)
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.